Skip to main content
. 2010 Jul 22;68(1):159–167. doi: 10.1007/s00018-010-0451-2

Table 2.

Functional characterization of TSHR mutations

Location Transfected construct Ballesteros and Weinstein numbering Cell surface expression cAMP accumulation IP accumulation
FACS% of TSHR wt EC50 nM TSH stimulated % of TSHR TSH stimulated % of TSHR
wt TSHR 100 1.2 (0.8–1.7) 100 100
TMH1 V424I 1.43 102 ± 10 3.0 (2.2–4.1) 98 ± 8 53 ± 4
TMH2 L467V 2.57 85 ± 8 11.2 (10.4–12.1) 105 ± 14 19 ± 1
TMH3 V502A 3.33 44 ± 4 4.3 (3.9–4.7) 84 ± 10 13 ± 0
TMH4 L552V 4.56 90 ± 5 1.0 (0.8–1.4) 84 ± 19 79 ± 11
TMH5 Y582A 5.39 71 ± 5 3.7 (2.6–5.2) 106 ± 19 45 ± 17
TMH5 Y582F 5.39 86 ± 8 1.9 (1.3–2.8) 108 ± 12 114 ± 18
TMH5 V586I 5.43 107 ± 6 1.1 (0.7–1.7) 82 ± 7 120 ± 6
TMH5 L589V 5.46 100 ± 12 1.1 (1.0–1.2) 90 ± 9 110 ± 11
TMH6 Y643A 6.54 99 ± 9 6.0 (4.5–8.0) 93 ± 9 47 ± 4
TMH7 L665V 7.40 95 ± 11 2.0 (2.0–2.0) 100 ± 10 71 ± 6

HEK 293 cells were transfected with wt TSHR and mutated TSHRs. The TSHR cell surface expression level was quantified on a FACS flow cytometer. Receptor expression was determined by the mean fluorescence intensity by comparison to wt TSHR. Stimulation was carried out with increasing concentrations of TSH. Results for cAMP accumulation were measured by RIA. Quantification of IP accumulation was done by [3H]Inositol incorporation studies. Data are given as mean ± SD of at least two independent experiments, each carried out in duplicate. EC50 values are shown as geometric mean (95% confidence limits). The pcDNA3 vector was used as a control